Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adenocarcinoma, Allergy, angioedema, antitumor, ascending, billion, bispecific, cavitation, cavity, CINDU, CIU, College, costimulation, couple, CSU, deficiency, degranulation, Delinquent, differentiation, disagreement, disaster, dramatic, Duke, exam, explanatory, gastroesophageal, gene, halt, Hampton, idiopathic, IgE, implicit, inactivating, induction, inhibitory, iniate, itchy, lab, leukotriene, markedly, merit, MSD, node, NOTCH, Omalizumab, onset, outage, outbreak, pain, pandemic, parental, PCT, play, power, protruding, purpose, role, roughly, SCF, scratching, sizeable, somatic, spread, strain, subvert, suppression, surfaced, symptomatic, transient, uPR, urticaria, Wuhan
Removed:
administered, adult, AEs, agonistic, andin, anniversary, assessing, assigned, attack, attributed, BRAF, broadly, calculated, called, CAM, captured, cascade, colorectal, complexity, composition, consummated, correlation, COSO, counterpart, diagnosed, discontinued, EGFR, encountered, enhanced, escalate, explore, fatigue, finalized, forma, gastrointestinal, GIST, glembatumumab, glioblastoma, gpNMB, greatest, growing, Haven, hematologic, Herceptin, highest, horizon, immunologic, impacting, improved, induced, intent, July, knowledge, leverage, LLP, malignant, Medarex, mediated, METRIC, mild, mobilize, moderate, nausea, nivolumab, novelty, ovarian, permissive, pointing, pro, promptly, published, randomized, RCC, recognizing, representing, Rintega, sample, select, sequence, Squibb, stromal, Tafinlar, tangible, Tarceva, theJournal, treating, UltiMab, unaudited, untapped, unusual, vedotin, vigorously, vivo, Zelboraf
Filing tables
Filing exhibits
Related press release
CLDX similar filings
Filing view
External links